A mitotically active, cellular tumor stroma and/or inflammatory cells associated with tumor cells may contribute to intermediate or high Oncotype DX Recurrence Scores in low-grade invasive breast carcinomas. (Q54333856)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 December 2011

Language	Label	Description	Also known as
English	A mitotically active, cellular tumor stroma and/or inflammatory cells associated with tumor cells may contribute to intermediate or high Oncotype DX Recurrence Scores in low-grade invasive breast carcinomas.	scientific article published on 16 December 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22173289

A mitotically active, cellular tumor stroma and/or inflammatory cells associated with tumor cells may contribute to intermediate or high Oncotype DX Recurrence Scores in low-grade invasive breast carcinomas. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22173289

author name string

Geza Acs

1

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22173289

Nicole N Esposito

2

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22173289

John Kiluk

3

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22173289

Loretta Loftus

4

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22173289

Christine Laronga

5

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22173289

publication date

16 December 2011

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22173289

Modern Pathology

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22173289

25

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22173289

4

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22173289

556-566

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22173289

Molecular evolution of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Histological and molecular types of breast cancer: is there a unifying taxonomy?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Breast cancer prognostic classification in the molecular era: the role of histological grade

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Omission of histologic grading from clinical decision making may result in overuse of adjuvant therapies in breast cancer: results from a nationwide study.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Long term prognostic value of Nottingham histological grade and its components in early (pT1N0M0) breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Pathology characteristics that optimize outcome prediction of a breast screening trial

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

ONCOPOOL - a European database for 16,944 cases of breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

A prognostic index in primary breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Confirmation of a prognostic index in primary breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Pathology of preinvasive and excellent prognosis breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Genomic signatures to guide the use of chemotherapeutics.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Invasive cribriform carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Tubular carcinoma of the breast: further evidence to support its excellent prognosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Tubular carcinoma of the breast: results of a large contemporary series

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Comparison of biochemical and histochemical techniques for estrogen receptor analyses in mammary carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

A molecular signature of the Nottingham prognostic index in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Racial differences in breast cancer survival in women under age 60.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Histopathologic variables predict Oncotype DX recurrence score

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

The Oncotype DX Recurrence Score Is Correlated With a Composite Index Including Routinely Reported Pathobiologic Features

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Association between standard clinical and pathologic characteristics and the 21-gene recurrence score in breast cancer patients: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

A Lower Allred Score for Progesterone Receptor Is Strongly Associated With a Higher Recurrence Score of 21-Gene Assay in Breast Cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

New targets for therapy in prostate cancer: modulation of stromal–epithelial interactions

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Prostate tumor-stroma interaction: molecular mechanisms and opportunities for therapeutic targeting

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

21 January 2018

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

7 January 2021

based on heuristic

inferred from DOI database lookup

Applying the Nottingham Prognostic Index to a Swedish breast cancer population. South East Swedish Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis of a series of 763 consecutive node-negative invasive breast cancer patients without adjuvant therapy: analysis of clinicopathological prognostic factor

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

7 January 2021

based on heuristic

inferred from DOI database lookup

Time-dependent effects on survival in breast carcinoma: results of 20 years of follow-up from the Swedish Two-County Study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990–1999

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathology of preinvasive and excellent-prognosis breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic Significance of Nottingham Histologic Grade in Invasive Breast Carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

7 January 2021

based on heuristic

inferred from DOI database lookup

Routine pathologic parameters can predict Oncotype DXTM recurrence scores in subsets of ER positive patients: who does not always need testing?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

7 January 2021

based on heuristic

inferred from DOI database lookup

Infiltrating cribriform carcinoma of the breast: a distinctive clinicopathologic entity

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting features of breast cancer with gene expression patterns

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

7 January 2021

based on heuristic

inferred from DOI database lookup

High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.194

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MODPATHOL.2011.194

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22173289

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22173289

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54333856&oldid=2212427957"